tirzepatide 2024 SUMMIT: Improves Outcomes and Quality of Life For Patients With HFpEF and Obesity Diabetes drug tirzepatide linked to

doi: 10.1016/j.diabres.2025.112278 178

semaglutide in healthy Chinese subjects

These effects are seen even outside of diabetes control.[ref] Related article: APOE genotype and Alzheimers risk Cardiovascular disease benefits: A number of studies have shown that GLP-1 RAs provide benefits for reducing cardiovascular disease

Weight Loss made easy with Semaglutide Semaglutide (The FDA-approved active ingredient in Wegovy and Ozempic) is a weekly shot that mimics your body's natural hormone GLP-1, reducing your cravings and helping you feel fuller faster and for longer

Although these changes in HR upon GLP-1 RA administration were subtle and the underlying mechanisms are unclear, further studies are necessary to elucidate the long-term effects of GLP-1 RAs primarily on HR and other related variables to clarify whether the elevated HR can be regarded as a transient reflex mechanism or whether it might in fact lead to poor cardiovascular outcomes in a diabetic population

Their effects on glucose regulation, weight, and overall metabolic health may indirectly influence how patients perceive their energy levels